InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ARS Pharmaceuticals, Inc.

SPRY Clue Score36
United States Fiscal year ends December CIK 0001671858 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

51
Insider
Date
Role
Action
Shares
Price
Amount
Eric Karas
12 Jun 2026
Chief Commercial Officer
Sold after exercise
25,000
$10.00
$250.00K
Brian Dorsey
13 Nov 2025
Chief Operating Officer
Sold after exercise
21,828
$8.71
$190.05K
Justin Chakma
12 Nov 2025
Chief Business Officer
Sold after exercise
136,380
$8.86
$1.21M
Justin Chakma
12 Nov 2025
Chief Business Officer
Sold after exercise
30,000
$8.91
$267.36K
Kathleen D. Scott
21 Aug 2025
Chief Financial Officer
Sold after exercise
12,500
$15.00
$187.50K
Eric Karas
1 Jul 2025
Chief Commercial Officer
Sold after exercise
15,000
$16.99
$254.86K
Eric Karas
18 Jun 2025
Chief Commercial Officer
Sold after exercise
15,000
$16.00
$240.00K
Kathleen D. Scott
20 May 2025
Chief Financial Officer
Sold after exercise
50,000
$14.10
$705.17K
Brent L Saunders
20 May 2025
Director
Sold after exercise
120,000
$14.25
$1.71M
Alexander A Fitzpatrick
20 May 2025
Chief Legal Officer
Sold after exercise
102,969
$14.10
$1.45M
Laura Shawver
7 Apr 2025
Director
Sold after exercise
50,002
$12.30
$615.07K
Eric Karas
20 Mar 2025
Chief Commercial Officer
Sold after exercise
10,000
$14.00
$140.00K
Laura Shawver
6 Mar 2025
Director
Sold after exercise
49,600
$11.21
$556.05K
Laura Shawver
5 Mar 2025
Director
Sold after exercise
400
$11.00
$4.40K
Laura Shawver
3 Feb 2025
Director
Sold after exercise
50,000
$12.31
$615.57K
Laura Shawver
6 Jan 2025
Director
Sold after exercise
50,000
$11.10
$555.07K
Justin Chakma
13 Dec 2024
Chief Business Officer
Sold after exercise
27,272
$12.06
$328.97K
Brian Dorsey
12 Dec 2024
Chief Operating Officer
Sold after exercise
25,000
$12.30
$307.43K
Justin Chakma
12 Dec 2024
Chief Business Officer
Sold after exercise
117,333
$12.27
$1.44M
Brian Dorsey
11 Dec 2024
Chief Operating Officer
Sold after exercise
15,000
$12.43
$186.43K
Justin Chakma
10 Dec 2024
Chief Business Officer
Sold after exercise
50,000
$13.15
$657.63K
Justin Chakma
6 Dec 2024
Chief Business Officer
Sold after exercise
50,000
$14.23
$711.62K
Justin Chakma
5 Dec 2024
Chief Business Officer
Sold after exercise
49,640
$14.13
$701.64K
Eric Karas
4 Dec 2024
Chief Commercial Officer
Sold after exercise
6,283
$14.00
$87.96K
Laura Shawver
4 Dec 2024
Director
Sold after exercise
14,772
$13.75
$203.11K
Justin Chakma
4 Dec 2024
Chief Business Officer
Sold after exercise
45,000
$13.95
$627.94K
Laura Shawver
3 Dec 2024
Director
Sold after exercise
87,984
$13.26
$1.17M
Justin Chakma
3 Dec 2024
Chief Business Officer
Sold after exercise
45,000
$13.19
$593.40K
Eric Karas
2 Dec 2024
Chief Commercial Officer
Sold after exercise
3,717
$14.11
$52.46K
Laura Shawver
2 Dec 2024
Director
Sold after exercise
901
$14.34
$12.92K
Laura Shawver
2 Dec 2024
Director
Sold after exercise
96,343
$13.55
$1.31M
Justin Chakma
2 Dec 2024
Chief Business Officer
Sold after exercise
45,000
$13.67
$615.22K
Kathleen D. Scott
16 Oct 2024
Chief Financial Officer
Sold after exercise
12,500
$16.00
$200.00K
Eric Karas
18 Sep 2024
Chief Commercial Officer
Sold after exercise
10,000
$14.00
$140.00K
Kathleen D. Scott
20 Aug 2024
Chief Financial Officer
Sold after exercise
12,500
$16.00
$200.00K
Brian Dorsey
20 Aug 2024
Chief Operating Officer
Sold after exercise
50,000
$15.00
$750.00K
Eric Karas
19 Aug 2024
Chief Commercial Officer
Sold after exercise
10,000
$14.00
$140.00K
Brian Dorsey
13 Aug 2024
Chief Operating Officer
Sold after exercise
30,000
$13.00
$390.00K
Laura Shawver
1 Sep 2023
Director
Sold after exercise
100,000
$7.71
$770.52K
Laura Shawver
4 Aug 2023
Director
Sold after exercise
18,897
$7.06
$133.47K
Laura Shawver
3 Aug 2023
Director
Sold after exercise
26,107
$7.01
$183.02K
Laura Shawver
2 Aug 2023
Director
Sold after exercise
36,281
$7.09
$257.26K
Laura Shawver
1 Aug 2023
Director
Sold after exercise
18,715
$7.19
$134.58K
Laura Shawver
7 Jul 2023
Director
Sold after exercise
8,858
$6.36
$56.37K
Laura Shawver
6 Jul 2023
Director
Sold after exercise
33,510
$6.34
$212.55K
Laura Shawver
5 Jul 2023
Director
Sold after exercise
31,112
$6.41
$199.55K
Laura Shawver
3 Jul 2023
Director
Sold after exercise
26,520
$6.73
$178.35K
Laura Shawver
2 Jun 2023
Director
Sold after exercise
26,941
$6.95
$187.24K
Laura Shawver
1 Jun 2023
Director
Sold after exercise
73,059
$6.80
$496.80K
Laura Shawver
9 May 2023
Director
Sold after exercise
42,900
$5.31
$227.80K
Laura Shawver
8 May 2023
Director
Sold after exercise
57,100
$6.16
$351.74K
Showing 250 of 261 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 231
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 149
Sales straight out of an exercise 51
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 84,407,624
History held since 7 Dec 2020